Disease modifying therapies for relapsing multiple sclerosis

Disease modifying therapies for relapsing multiple sclerosis

Item
http://www.wikidata.org/entity/Q26739903
Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis.Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis.A novel class of somatic mutations in blood detected preferentially in CD8+ cellsConjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational studyMetabolic pathways as possible therapeutic targets for progressive multiple sclerosis.Transcriptional regulators of redox balance and other homeostatic processes with the potential to alter neurodegenerative disease trajectory.Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database.Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study.Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod.Efficacy of alemtuzumab and natalizumab in the treatment of different stages of multiple sclerosis patients.Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.Efficacy of Synthetic Peptide Corresponding to the ACTH-Like Sequence of Human Immunoglobulin G1 in Experimental Autoimmune Encephalomyelitis.High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study.
P2860

Disease modifying therapies for relapsing multiple sclerosis

Item
http://www.wikidata.org/entity/Q26739903
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Disease modifying therapies for relapsing multiple sclerosis
@ast
Disease modifying therapies for relapsing multiple sclerosis
@en
Disease modifying therapies for relapsing multiple sclerosis
@nl
type
label
Disease modifying therapies for relapsing multiple sclerosis
@ast
Disease modifying therapies for relapsing multiple sclerosis
@en
Disease modifying therapies for relapsing multiple sclerosis
@nl
prefLabel
Disease modifying therapies for relapsing multiple sclerosis
@ast
Disease modifying therapies for relapsing multiple sclerosis
@en
Disease modifying therapies for relapsing multiple sclerosis
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P577
P698
P921
P356
P1433
P1476
Disease modifying therapies for relapsing multiple sclerosis
@en
P2093
P304
P31
P356
P407
P478
P577
P698
P921